-

Dr. Yew Kuo Chao: The future treatment direction of MAFLD will be more personalized
Recently, the Combined GlHep&SHC 2024 was successfully held in Singapore. This conference covers various aspects of liver disease research and provides an interdisciplinary communication platform for experts and scholars. During the conference, Hepatology Digest invited Dr. Yew Kuo Chao, a senior consultant at Tan Tock Seng Hospital, Singapore, to discuss topics related to metabolic associated…
-

2024 CUDA丨Dr. Weijun Qin: Unprecedented CUDA Conference Advances Urology, Innovations in Xenotransplantation Enhance Patient Benefits
From August 8th to 11th, 2024, the Annual Meeting of the Urology Physicians Branch of the Chinese Medical Doctor Association (CUDA) was held in Xi’an. The conference was hosted by the Chinese Medical Doctor Association and the Urology Physicians Branch, organized by Xijing Hospital of the Air Force Medical University, and co-organized by the Urology…
-

2024 CUDA丨Dr. Sujun Han: Prostate Cancer Quality Control Indicators Aid in Standardizing Diagnosis and Treatment, Enhancing Both Survival and Quality
Prostate cancer is the most common malignancy of the male genitourinary system. Compared to Western countries, a larger proportion of prostate cancer patients in China are diagnosed at intermediate to advanced stages, leading to poorer prognosis. At the recent 2024 Annual Meeting of the Urology Physicians Branch of the Chinese Medical Doctor Association (CUDA), Urology…
-

2024 CUDA丨Dr. Nianzeng Xing: Special Sessions Propel New Productivity in Urology, Highlighting the Spirit of International Collaboration in Healthcare
In the journey toward a “Healthy China,” urology leads the way. From August 9th to 11th, 2024, the eagerly anticipated 2024 Annual Meeting of the Urology Physicians Branch of the Chinese Medical Doctor Association was grandly held in Xi’an. With a broad global perspective, the conference showcased the latest achievements in the field of urology…
-

2024 COMB丨Dr. Songqing Ye: Exploring the Development of CDK4/6 Inhibitors, ADCs, and Immunotherapy in Early-Stage Breast Cancer
From August 2-4, 2024, the 7th Oncology Precision Diagnosis and Treatment Conference and the 10th Breast Cancer Individualized Treatment Conference (COMB), organized by the China Cancer Foundation and Beijing Breast Disease Prevention Society, was grandly held in Beijing. The conference brought together the latest advances in individualized precision treatment for breast cancer in China, providing…
-

2024 COMB丨Dr. Yanxia Zhao: Comprehensive Considerations for Radiotherapy Exemption and Hypofractionated Radiotherapy in Clinical Practice
From August 2-4, 2024, the 7th Oncology Precision Diagnosis and Treatment Conference and the 10th Breast Cancer Individualized Treatment Conference (COMB), organized by the China Cancer Foundation and Beijing Breast Disease Prevention Society, was grandly held in Beijing. The conference gathered the latest advancements in individualized precision treatment for breast cancer in China and provided…
-

AIDS Interview | Enhancing Immune Protection for HIV-Positive Individuals: Tailored Vaccination Strategies
In the field of AIDS prevention and treatment, tailored immunization strategies for HIV-positive individuals are becoming crucial for improving patients’ quality of life and prolonging their lifespan. At the 25th International AIDS Conference (AIDS 2024), Dr. Anna Maria Geretti from the Institute of Infection and Global Health, University of Liverpool presented an insightful report on…
-

AIDS Interview | Doxycycline Pre-Exposure Prophylaxis Shows Significant Effects in Preventing STIs Among HIV-Positive Individuals
At the 25th International AIDS Conference, a study led by Dr. Troy Grennan from the British Columbia University and the Canadian Centre for Disease Control revealed the astonishing effectiveness of doxycycline pre-exposure prophylaxis (DoxyPrEP) in reducing the incidence of bacterial sexually transmitted infections (STIs) among HIV-positive men who have sex with men. The study found…